跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 160 条关于
“NTB003”
全部
160
临床试验
96
药物
44
机构
0
资讯
20
去年
Biocytogen and Nanjing Chia Tai Tianqing Receive IND Approval for Second-Generation Anti-IGF-1R Antibody NTB003 in Thyroid Eye Disease
去年
Cybin's CYB003 Shows Sustained Remission in Major Depressive Disorder After 12 Months
去年
Cybin Bolsters Clinical Team as CYB003 Phase 3 Trial Nears
去年
Cybin's CYB003 Enters Phase 3 Trials for Major Depressive Disorder
去年
Cybin Initiates Phase 3 Trial of CYB003 for Major Depressive Disorder
去年
Cybin's CYB003 Demonstrates Sustained Efficacy in Phase 2 Trial for Major Depressive Disorder
去年
Cybin's CYB003 Demonstrates Sustained Efficacy in Phase 2 Trial for Major Depressive Disorder
去年
Cybin Advances CYB003 into Phase 3 for Major Depressive Disorder
去年
Cybin's CYB003 Shows Sustained Efficacy in Phase 2 Depression Study
9个月前
Novadip Initiates Pivotal Phase 3 Trial of NVD003 for Rare Pediatric Bone Condition
第 1 页,共 2 页
上一页
下一页